Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
Classifica tra le azioni #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
Prezzo delle azioni
$0.16328419
Capitalizzazione di mercato
$204.14K
Variazione (1 giorno)
4.35%
Variazione (1 anno)
102.45%
Paese
GB
Scambia Fusion Antibodies plc (FAB)

Categoria

EPS per Fusion Antibodies plc (FAB)
EPS al September 2025 TTM: $-0.02
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Fusion Antibodies plc, l’EPS attuale della società (TTM) è $-0.02. Alla fine del 2024, la società aveva un EPS di $-0.05 una diminuzione rispetto a rispetto a quello del 2023, che era di $-0.12.
Storico EPS per Fusion Antibodies plc da 2013 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-0.02 -3.00%
2025 $-0.02 -54.35%
2024 $-0.05 -58.93%
2023 $-0.12 102.30%
2022 $-0.06 -59.83%
2021 $-0.15 286.73%
2020 $-0.04 -47.38%
2019 $-0.07 22.53%
2018 $-0.06 -994.12%
2017 $0.01 -90.93%
2016 $0.08 -1,393.10%
2015 $-0.01 -31.76%
2014 $-0.01 -73.60%
2013 $-0.03 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$3.62 -18,771.65%
DK
$15.47 -79,842.27%
US
$43.12 -222,368.04%
US
$9.62 -49,691.75%
BE
$38.32 -197,625.77%
NL